PTX to me is the most undervalued Bio on the ASX hands down.
PTX200 during phase 1b result had an overall response rate of 50% against industry average ORR of 25%.
Folotyn which only has an ORR of 27% had sales of over $4.5 billion last year
If results from current trials are above 27% don't you think people will start using PTXs
Results from 3 trials coming this quarter have me really excited
If PTX could become a billion dollar company its's share price would be over $2.50
Multi bagger potential here guys!
PTX to me is the most undervalued Bio on the ASX hands...
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $32.21M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 4.0¢ | 3.9¢ | $35.17K | 896.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 350000 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 163887 | 2 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| PTX (ASX) Chart |